We use cookies to improve your browsing experience and provide meaningful content. Read our cookie policy. Accept
  •  Customer Login
  • Register
  •  View Cart (0)
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us

Clontech Takara Cellartis

Close

  • ‹ Back to CRISPR/Cas9 knockins
  • Choosing an HDR template format
  • Homology-directed repair FAQs
  • Mouse CRISPR knockin protocol
  • Site-specific gene knockins using long ssDNA
  • Efficient CRISPR/Cas9-mediated knockins in iPS cells
  • Oligo design tool for detecting precise insertions
Expression of AcGFP1-tagged tubulin in iPS cells Efficient gene knockins in iPS cells using ssDNA
Tech note: efficient SNP engineering Tech note: efficient SNP screening
Home › Learning centers › Gene function › Gene editing › CRISPR/Cas9 knockins › Homology-directed repair FAQs

Gene editing

  • Gene editing product finder
  • Gene editing tools and information
    • sgRNA design tools
    • Tools for successful CRISPR/Cas9 genome editing
    • Gene editing posters
    • Customer data for Guide-it products
    • How to design sgRNA sequences
    • Introduction to the CRISPR/Cas9 system
    • Gene editing of CD3+ T cells and CD34+ HSCs
  • CRISPR/Cas9 knockouts
    • Mutation detection kit comparison
    • Screening for effective guide RNAs
    • Monoallelic versus biallelic mutants
    • Indel identification kit for mutation characterization
  • CRISPR/Cas9 knockins
    • Choosing an HDR template format
    • Homology-directed repair FAQs
    • Mouse CRISPR knockin protocol
    • Site-specific gene knockins using long ssDNA
    • Efficient CRISPR/Cas9-mediated knockins in iPS cells
    • Oligo design tool for detecting precise insertions
      • Oligo design tool user guide (insertions)
  • Genome-wide screening
    • CRISPR library screening
    • CRISPR library screening webinar
    • Phenotypic screen using sgRNA library system
  • Creating and screening for SNPs
    • SNP detection with knockin screening kit
    • Oligo design tool for SNP screening
      • Oligo design tool user guide (SNPs)
    • Sign up: SNP engineering webinar
    • Guide-it SNP Screening Kit FAQs
  • CRISPR/Cas9 delivery methods
    • Electroporation-grade Cas9 for editing in diverse cell types
    • CRISPR/Cas9 gene editing with AAV
    • CRISPR/Cas9 gesicles overview
    • Cas9 Gesicles—reduced off-target effects
    • sgRNA-Cas9 delivery to many cell types
    • Tet-inducible Cas9 for gene editing
  • Cre recombinase
    • Control your Cre recombinase experiments
    • Fast Cre delivery with gesicle technology
New products
Need help?
Contact Sales
Expression of AcGFP1-tagged tubulin in iPS cells Efficient gene knockins in iPS cells using ssDNA
Tech note: efficient SNP engineering Tech note: efficient SNP screening

Homology-directed repair FAQs

A powerful application of CRISPR/Cas genome editing technology involves the precise insertion or substitution of DNA sequences at specific genomic loci via the homology-directed repair (HDR) pathway. While this approach for engineering site-specific knockins is becoming increasingly popular, there are many ways to go about it, and its efficiency can vary widely depending on factors such as the target organism or cell type, the genomic locus, or the DNA template.

To maximize your likelihood for success with genome editing using HDR, our R&D team has compiled responses for the following frequently asked questions:

How do I design my HDR template?

The sequence of the HDR template should match the intended sequence of the targeted genomic locus, including the desired edit flanked by 5' and 3' ends that share homology with the wild-type genomic locus. (These 5' and 3' sequences are referred to as "homology arms.")

Sequences corresponding to desired edits (insertions, substitutions, etc.) should be positioned in the middle of the HDR template. The exact sequence of the HDR template is independent of the position of the single guide RNA (sgRNA) or the cut site of the Cas9 nuclease, but efficient editing requires a template design in which the sequence(s) to be inserted are in relatively close proximity to the cut site of the Cas9-sgRNA ribonucleoprotein (RNP). (See FAQ below for more detail.)

The figure below demonstrates the design of HDR templates for engineering a single nucleotide substitution or a longer insertion, respectively, at corresponding genomic loci.

HDR template design examples

Figure 1. Examples of HDR template designs for engineering a single nucleotide substitution or insertion of a sequence. In either case, the HDR template should encode the final desired edit with 5' and 3' flanking sequences homologous to the wild-type target site. Panel A. Design of an HDR template for engineering the mutation g.1488C>T in the RECQL4 gene. The mutated base is shown in red. Panel B. Design of an HDR template for inserting a myc tag at the C terminus of the UGT1A9 gene. In this case, three different sgRNAs were designed to target sites in close proximity to the location of the intended insertion.

What are the advantages and disadvantages of using single-stranded vs. double-stranded HDR templates for engineering gene knockins?

It has been demonstrated that the use of ssDNA results in lower toxicity and reduced frequencies of random integration relative to dsDNA (Roth et al. 2018; Li et al. 2017), benefits which can be especially important when working with difficult-to-engineer cell lines. For example, if you are seeking to fuse a fluorescent protein to an endogenous gene expressed in your target cells, the percentage of fluorescent cells in the overall edited population could be used as a proxy for the frequency of successful HDR. However, some subset of these fluorescent cells could have resulted from random integration of the HDR template in frame with a gene other than the intended genomic target. (Panel 4B in this poster includes data from our R&D team demonstrating this phenomenon.) Such events are less probable when ssDNA is used as a template for HDR.

References

Li, H et al., Design and specificity of long ssDNA donors for CRISPR-based knock-in. bioRxiv doi: https://doi.org/10.1101/178905 (2017).

Roth, T.L et al., Reprogramming human T cell function and specificity with non-viral genome targeting. Nat. Lett. 559, 405–409 (2018).

How do ssODNs differ from ssDNA? When is it better to use one vs. the other?

Single-stranded oligo deoxynucleotides (ssODNs) are produced routinely via chemical synthesis and can be used for engineering smaller edits (e.g., single nucleotide substitutions or shorter insertions <50 nt) as HDR templates with a total maximum length of 200 nt. For engineering larger insertions that necessitate HDR templates >500 nt, we recommend the use of ssDNA that can be produced with the Guide-it Long ssDNA Production System.

With ssODN or ssDNA, is it advantageous to use HDR templates that are homologous to the sense or antisense strand at the genomic target region?

Currently, there is no clear rule regarding the preferential use of sense or antisense ssDNA for HDR templates longer than 200 nt. However, in the case of shorter single-stranded oligodeoxynucleotide (ssODN) templates, template polarity has been found to have an effect on efficiency (Bollen et al. 2018).

References

Bollen, Y., Post, J., Koo, B. & Snippert, H.J.G How to create state-of-the-art genetic model systems: strategies for optimal CRISPR-mediated genome editing. Nuc. Acid. Res. 46, 6435–6454 (2018).

What are optimal lengths for HDR template homology arms?

It has been demonstrated that there is an exponential relationship between homology arm length and knockin efficiency, with ssDNA templates including homology arms 350–700 nt in length providing optimal performance (Li et al. 2017). In our own studies involving hiPSCs, optimal performance was observed with 350-nt homology arms, and the use of longer arms did not substantially increase knockin efficiencies.

It is important to note that using longer homology arms will increase the molecular weight of your HDR template, and since the amounts of HDR template used for electroporation are usually measured in µg, longer homology arms will correspond with fewer mols (copies) of template being introduced in the target cells, possibly impacting the overall percentage of HDR.

References

Li, H et al., Design and specificity of long ssDNA donors for CRISPR-based knock-in. bioRxiv doi: https://doi.org/10.1101/178905 (2017).

Is it helpful to use HDR templates that introduce silent mutations in the PAM sequence or sgRNA seeding region?

Cas9-sgRNA RNPs can re-cut a given genomic target following HDR if the editing outcome does not involve alteration of the PAM or sgRNA seeding region in the protospacer sequence, such that the RNP complex can still bind to the genomic target. Given this, a common strategy for increasing the percentage of successful HDR in coding regions is the incorporation of silent mutations in HDR templates that disrupt Cas9-sgRNA RNP binding without altering corresponding amino acid sequences.

If your PAM sequence is in a coding region and it can be silently mutated, it is advisable to do so to maximize the precision of genome editing and prevent subsequent Cas9 re-cutting and indel creation following HDR (Paquet et al. 2016). In seeking to mutate the PAM to disrupt RNP binding, please take into account other canonical PAM sequences (different from NGG) that can also be recognized less effectively by SpCas9 (i.e., NAG or NGA) (Zhang et al. 2014; Hsu et al. 2013) or Cas12a (i.e., TCTA, TCCA, or CCCA) (Yamano et al. 2017). Presented in the figure below are data demonstrating improved editing performance via incorporation of PAM mutations in HDR templates.

As mentioned above, the protospacer sequence can also be mutated. However, since some guide RNAs may tolerate a mismatch in the binding sequence, we recommend changing several bases as close to the PAM as possible in the seeding region of the sgRNA (Paquet et al. 2016; Kwart et al. 2017).

Improved genome editing performance via mutation of PAM sequence

Figure 2. Improved genome editing performance via mutation of PAM sequences. The UGT1A9 gene was tagged with a myc tag (depicted in yellow, lowercase nucleotides) at its C terminus, just before the STOP codon (TGA, depicted in grey). Three different sgRNAs were designed to target genomic sites close to the intended insertion site, and all three of them were tested independently. ChiPSC18 cells were electroporated with RNP complexes together with two different HDR donors: one encoding for the intended myc-tag fusion with no additional mutations, and another encoding for the fusion as well as mutations in all three PAM sites of the corresponding sgRNAs. After electroporation, HDR efficiencies for the different samples were analyzed using the Guide-it SNP Screening Kit, which detects seamless insertion of the tag at its 5' and 3' ends, yielding green and red fluorescent signals, respectively. The highest signal for both wavelengths corresponded to the use of sgRNA3 in tandem with the HDR template with the mutated PAM sites. In parallel, HDR efficiencies were also analyzed using an RFLP-based method involving a new NdeI site created by the insertion of the myc tag. For this analysis, a signal could only be detected for cells edited using sgRNA3 in tandem with the HDR template carrying mutated PAM sites (i.e., the same cells that yielded the strongest fluorescent signals in the Guide-it screening assay).

References

Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827–32 (2013).

Kwart, D., Paquet, D., Teo, S. & Tessier-Lavigne, M. Precise and efficient scarless genome editing in stem cells using CORRECT. Nat. Protoc. 12, 329–354 (2017).

Paquet, D. et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533, 125–129 (2016).

Yamano, T. et al. Structural Basis for the Canonical and Non-canonical PAM Recognition by CRISPR-Cpf1. Mol. Cell 67, 633–645.e3 (2017).

Zhang, Y. et al. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells. Sci. Rep. 4, doi: 10.1038/srep05405 (2014).

Does the HDR insertion site need to be directly next to the PAM?

It is highly recommended that the HDR insertion site is positioned within 10 nt upstream or downstream of the Cas9-sgRNA RNP cut site. For wild-type SpCas9, this is located 3–4 nucleotides upstream of the PAM. It has been demonstrated that there is an inverse relationship between HDR efficiency and the distance between the insertion site and Cas9-gRNA RNP cut site (Paquet et al. 2016).

References

Paquet, D. et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533, 125–129 (2016).

What are the effects of chromatin configuration on HDR efficiency?

It has been demonstrated that nucleosomes inhibit target cleavage by SpCas9 in vivo, suggesting that Cas9 activity is influenced by chromatin structure in addition to the inherent activity of a given sgRNA (Yarrington et al. 2018). Although DNA sequence is a significant determinant of site-specific indel profiles, it has been shown that packaging of DNA into chromatin may influence editing efficiency and the relative frequency of indels at a given locus (Chakrabarti et al. 2018). On the other hand, using imprinted genes as a test case, outcomes of gene editing events (i.e., the balance between HDR vs. NHEJ) were shown to be independent of chromatin state (Kallimasioti-Pazi et al. 2018).

References

Chakrabarti, A. M. et al. Target-Specific Precision of CRISPR-Mediated Genome Editing. Mol. Cell 73, 1–15 (2018).

Kallimasioti-Pazi, E. M. et al. Heterochromatin delays CRISPR-Cas9 mutagenesis but does not influence the outcome of mutagenic DNA repair. PLOS Biol. 16, e2005595 (2018).

Yarrington, R. M., Verma, S., Schwartz, S., Trautman, J. K. & Carroll, D. Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo. Proc. Natl. Acad. Sci. 115, 9351–9358 (2018).

What are additional methods for improving HDR efficiency?

The development of novel methods for improving HDR efficiency is currently a major focus area in the genome editing field. Toward this end, the following approaches have shown promise:

  • Fusion or attachment of Cas9-sgRNA RNP and template (Aird et al. 2018; Savic et al. 2018; Carlson-Stevermer et al. 2017)
  • Restriction of Cas9 expression to S and G2 phases of the cell cycle, when the propensity for HDR is highest (Gutschner et al. 2016)
  • Development of base editing for engineering single nucleotide substitutions (Rees and Liu 2018)
  • Application of various chemical compounds that increase the percentage of HDR (Wienert et al. 2018; Riesenberg and Maricic 2018)

References

Aird, E. J., Lovendahl, K. N., St. Martin, A., Harris, R. S. & Gordon, W. R. Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template. Commun. Biol. 1, 54 (2018).

Carlson-Stevermer, J. et al. Assembly of CRISPR ribonucleoproteins with biotinylated oligonucleotides via an RNA aptamer for precise gene editing. Nat. Commun. 8, 1711 (2017).

Gutschner, T., Haemmerle, M., Genovese, G., Draetta, G. F. & Chin, L. Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair. Cell Rep. 14, 1555–1566 (2016).

Rees, H. A. & Liu, D. R. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat. Rev. Genet. 19, 770–788 (2018).

Riesenberg, S. & Maricic, T. Targeting repair pathways with small molecules increases precise genome editing in pluripotent stem cells. Nat. Commun. 9, 2164 (2018).

Savic, N. et al. Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair. Elife 7, (2018).

Wienert, B. et al. Timed inhibition of CDC7 increases CRISPR-Cas9 mediated templated repair. bioRxiv 500462 (2018). doi:10.1101/500462

How can I increase the frequencies of edited clones with only one modified allele and the other one encoding the wild-type sequence?

One of the most common genome editing outcomes is the introduction of an SNP in one allele and an indel in the other, such that it is especially challenging to obtain clones in which only one allele is modified (encoding for the desired edit) and the other one is unedited. To more efficiently obtain clones with SNP/wild-type heterozygosity, researchers have developed two strategies (Paquet et al. 2016):

  • Use an sgRNA with a cut site farther away from the insertion site (>10 nt)
  • Use an equal mix of mutant and wild-type HDR templates (one encoding for the SNP, the other encoding for the wild-type allele, both with the PAM sequence modified as explained in the previous FAQ)

Reference

Paquet, D. et al. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533, 125–129 (2016).


CRISPR/Cas9 information

Choosing sgRNA design tools

Browse a collection of sgRNA design tools for Cas9-based genome editing experiments.

Choosing a target sequence for CRISPR/Cas9 gene editing

Learn how to design sgRNA sequences for successful gene editing.

The CRISPR/Cas9 system for targeted genome editing

Overview of CRISPR/Cas9 system for genome editing.

CRISPR/Cas9 genome editing tools

An overview of tools available for each step in a successful genome editing workflow.

Gene editing technical notes

Delivery of Cas9 and sgRNA to mammalian cells using a variety of innovative tools.

SNP engineering application note

Learn about a simple assay for sensitive detection of single-nucleotide substitutions in bulk-edited or clonal cell populations.

CRISPR/Cas9 gesicles overview

Learn about Guide-it CRISPR/Cas9 Gesicle Production System components and workflow.

CRISPR library screening webinar

Watch this webinar to learn how you can perform genome-wide lentiviral sgRNA screens easily.

Choosing an HDR template format

Watch a webinar on how to choose the right HDR template for knockin experiments.

Guide-it SNP Screening Kit FAQs

Get answers to frequently asked questions and view a video explaining the enzymatic assay.

Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2025 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.

Takara Bio

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Support
  • Contact us
  • Technical support
  • Customer service
  • Shipping & delivery
  • Sales
  • Feedback
Products
  • New products
  • Special offers
  • Instrument & reagent services
Learning centers
  • NGS
  • Gene function
  • Stem cell research
  • Protein research
  • PCR
  • Cloning
  • Nucleic acid purification
About
  • Our brands
  • Careers
  • Events
  • Blog
  • Need help?
  • Announcements
  • Quality and compliance
  • That's Good Science!
Facebook Twitter  LinkedIn

logo strip white

©2025 Takara Bio Inc. All Rights Reserved.

Region - North America Privacy Policy Terms and Conditions Terms of Use

Top



  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISAs
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • New products
  • Special offers
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing services
  • Services
  • Facilities
  • Our process
  • Resources
  • Customer service
  • Sales
  • Make an appointment with your sales rep
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • GoStix Plus FAQs
  • Partnering & Licensing
  • Vector information
  • Vector document overview
  • Vector document finder
Takara Bio's award-winning GMP-compliant manufacturing facility in Kusatsu, Shiga, Japan.

Partner with Takara Bio!

Takara Bio is proud to offer GMP-grade manufacturing capabilities at our award-winning facility in Kusatsu, Shiga, Japan.

  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Spatial biology
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • Antibodies and ELISA
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
Create a web account with us

Log in to enjoy additional benefits

Want to save this information?

An account with takarabio.com entitles you to extra features such as:

•  Creating and saving shopping carts
•  Keeping a list of your products of interest
•  Saving all of your favorite pages on the site*
•  Accessing restricted content

*Save favorites by clicking the star () in the top right corner of each page while you're logged in.

Create an account to get started

  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Our brands
  • Our history
  • In the news
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • Trademarks
  • License statements
  • Quality statement
  • HQ-grade reagents
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
  • Website FAQs

That's GOOD Science!

What does it take to generate good science? Careful planning, dedicated researchers, and the right tools. At Takara Bio, we thoughtfully develop exceptional products to tackle your most challenging research problems, and have an expert team of technical support professionals to help you along the way, all at superior value.

Explore what makes good science possible

 Customer Login
 View Cart (0)
Takara Bio
  • Home
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us
  •  Customer Login
  • Register
  •  View Cart (0)

Takara Bio USA, Inc. provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. As a member of the Takara Bio Group, Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.

FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES (EXCEPT AS SPECIFICALLY NOTED).

Clontech, TaKaRa, cellartis

  • Products
  • COVID-19 research
  • Next-generation sequencing
  • Real-time PCR
  • Stem cell research
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Nucleic acid purification
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • New products
  • Special offers
  • COVID-19 research
  • Viral detection with qPCR
  • SARS-CoV-2 pseudovirus
  • Human ACE2 stable cell line
  • Viral RNA isolation
  • Viral and host sequencing
  • Vaccine development
  • CRISPR screening
  • Drug discovery
  • Immune profiling
  • Publications
  • Next-generation sequencing
  • Spatial omics
  • RNA-seq
  • DNA-seq
  • Single-cell NGS automation
  • Reproductive health
  • Bioinformatics tools
  • Immune profiling
  • Real-time PCR
  • Great value master mixes
  • Signature enzymes
  • High-throughput real-time PCR solutions
  • Detection assays
  • References, standards, and buffers
  • Stem cell research
  • Media, differentiation kits, and matrices
  • Stem cells and stem cell-derived cells
  • mRNA and cDNA synthesis
  • In vitro transcription
  • cDNA synthesis kits
  • Reverse transcriptases
  • RACE kits
  • Purified cDNA & genomic DNA
  • Purified total RNA and mRNA
  • PCR
  • Most popular polymerases
  • High-yield PCR
  • High-fidelity PCR
  • GC rich PCR
  • PCR master mixes
  • Cloning
  • In-Fusion seamless cloning
  • Competent cells
  • Ligation kits
  • Restriction enzymes
  • Nucleic acid purification
  • Automated platforms
  • Plasmid purification kits
  • Genomic DNA purification kits
  • DNA cleanup kits
  • RNA purification kits
  • Gene function
  • Gene editing
  • Viral transduction
  • Fluorescent proteins
  • T-cell transduction and culture
  • Tet-inducible expression systems
  • Transfection reagents
  • Cell biology assays
  • Protein research
  • Purification products
  • Two-hybrid and one-hybrid systems
  • Mass spectrometry reagents
  • Antibodies and ELISA
  • Primary antibodies and ELISAs by research area
  • Fluorescent protein antibodies
  • Services & Support
  • OEM
  • Instrument services
  • Gene and cell therapy manufacturing
  • Customer service
  • Sales
  • Shipping & delivery
  • Technical support
  • Feedback
  • Online tools
  • Partnering & Licensing
  • Vector information
  • OEM
  • Portfolio
  • Process
  • Facilities
  • Request samples
  • FAQs
  • Instrument services
  • Apollo services
  • ICELL8 services
  • SmartChip ND system services
  • Gene and cell therapy manufacturing
  • Services
  • Facilities
  • Our process
  • Resources
  • Sales
  • Make an appointment with your sales rep
  • Online tools
  • GoStix Plus FAQs
  • Vector information
  • Vector document overview
  • Vector document finder
  • Learning centers
  • Automation systems
  • Next-generation sequencing
  • Spatial biology
  • Real-time PCR
  • Nucleic acid purification
  • mRNA and cDNA synthesis
  • PCR
  • Cloning
  • Stem cell research
  • Gene function
  • Protein research
  • Antibodies and ELISA
  • Automation systems
  • Shasta Single Cell System introduction
  • SmartChip Real-Time PCR System introduction
  • ICELL8 introduction
  • Next-generation sequencing
  • RNA-seq
  • Technical notes
  • Technology and application overviews
  • FAQs and tips
  • DNA-seq protocols
  • Bioinformatics resources
  • Webinars
  • Real-time PCR
  • Download qPCR resources
  • Overview
  • Reaction size guidelines
  • Guest webinar: extraction-free SARS-CoV-2 detection
  • Technical notes
  • Nucleic acid purification
  • Nucleic acid extraction webinars
  • Product demonstration videos
  • Product finder
  • Plasmid kit selection guide
  • RNA purification kit finder
  • mRNA and cDNA synthesis
  • mRNA synthesis
  • cDNA synthesis
  • PCR
  • Citations
  • PCR selection guide
  • Technical notes
  • FAQ
  • Cloning
  • Automated In-Fusion Cloning
  • In-Fusion Cloning general information
  • Primer design and other tools
  • In‑Fusion Cloning tips and FAQs
  • Applications and technical notes
  • Stem cell research
  • Overview
  • Protocols
  • Technical notes
  • Gene function
  • Gene editing
  • Viral transduction
  • T-cell transduction and culture
  • Inducible systems
  • Cell biology assays
  • Protein research
  • Capturem technology
  • Antibody immunoprecipitation
  • His-tag purification
  • Other tag purification
  • Expression systems
  • APPLICATIONS
  • Molecular diagnostics
  • mRNA and protein therapeutics
  • Pathogen detection
  • Immunotherapy research
  • Cancer research
  • Alzheimer's disease research
  • Reproductive health technologies
  • Infectious diseases
  • Molecular diagnostics
  • Interview: adapting to change with Takara Bio
  • Applications
  • Solutions
  • Partnering
  • Contact us
  • mRNA and protein therapeutics
  • Characterizing the viral genome and host response
  • Identifying and cloning protein targets
  • Expressing and purifying protein targets
  • Immunizing mice and optimizing vaccines
  • Pathogen detection
  • Sample prep
  • Detection methods
  • Identification and characterization
  • SARS-CoV-2
  • Antibiotic-resistant bacteria
  • Food crop pathogens
  • Waterborne disease outbreaks
  • Viral-induced cancer
  • Immunotherapy research
  • T-cell therapy
  • Antibody therapeutics
  • T-cell receptor profiling
  • TBI initiatives in cancer therapy
  • Cancer research
  • Kickstart your cancer research with long-read sequencing
  • Sample prep from FFPE tissue
  • Sample prep from plasma
  • Cancer biomarker quantification
  • Single cancer cell analysis
  • Cancer transcriptome analysis
  • Cancer genomics and epigenomics
  • HLA typing in cancer
  • Gene editing for cancer therapy/drug discovery
  • Alzheimer's disease research
  • Antibody engineering
  • Sample prep from FFPE tissue
  • Single-cell sequencing
  • Reproductive health technologies
  • Embgenix FAQs
  • Preimplantation genetic testing
  • ESM partnership program
  • ESM Collection Kit forms
  • Infectious diseases
  • Develop vaccines for HIV
  • About
  • BioView blog
  • That's Good Science!
  • Our brands
  • Our history
  • In the news
  • Events
  • Careers
  • Trademarks
  • License statements
  • Quality and compliance
  • HQ-grade reagents
  • International Contacts by Region
  • Need help?
  • Website FAQs
  • BioView blog
  • Automation
  • Cancer research
  • Career spotlights
  • Current events
  • Customer stories
  • Gene editing
  • Research news
  • Single-cell analysis
  • Stem cell research
  • Tips and troubleshooting
  • Women in STEM
  • That's Good Support!
  • About our blog
  • That's Good Science!
  • SMART-Seq Pro Biomarker Discovery Contest
  • DNA extraction educational activity
  • That's Good Science Podcast
  • Season one
  • Season two
  • Season three
  • Events
  • Biomarker discovery events
  • Calendar
  • Conferences
  • Speak with us
  • Careers
  • Company benefits
  • International Contacts by Region
  • United States and Canada
  • China
  • Japan
  • Korea
  • Europe
  • India
  • Affiliates & distributors
  • Need help?
  • Privacy request
Takara Bio
  • Products
  • Services & Support
  • Learning centers
  • APPLICATIONS
  • About
  • Contact Us